You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Product Development of Intensity Modulation for Bolus Electron Conformal Therapy
SBC: Decimal, LLC Topic: 102Project Summary Abstract Electron beam therapy EBT using MeV beams provides effective radiation treatment for superficial cancers depthandlt cm As many as of radiotherapy patients in USA annually are eligible for electron therapy for some portion of their treatment making it the second most used external beam modality As many as of these electron patients ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Cognitive Change Battery: An Assessment for Serial Administration
SBC: COGMETRIC LLC Topic: NIAABSTRACT Detecting change in neuropsychological functioning over time is critical for proper diagnosis and management of many neurological psychiatric and psychological conditions It is well documented that most commonly used cognitive assessments produce significant retest effects such as practice and regression to the mean effects Retest effects can cause substantial changes in test score ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
An Agent-Based Modeling Platform for Environmental Biotechnology
SBC: MICROVI BIOTECH, INC. Topic: NIEHSDESCRIPTION provided by applicant Hazardous compounds in waters and soils are subject to a complex dynamic web of interactions among physical chemical and biological constituents in the natural environment Computational modeling has been proven indispensable to hazardous substances remediation particularly integrated modeling of pollutant hydrogeological fate and transport For the first t ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Evaluation of SBP-101 for the Treatment of Acute Pancreatitis
SBC: SUN BIOPHARMA, INC. Topic: 300Project Summary Pancreatitis is a significant public health problem accounting for over $ Billion of health care costs annually Approximately one third of patients with acute pancreatitis will go on to have recurrent pancreatitis Of those about will progress to chronic pancreatitis a painful disease with an increased risk of both diabetes and pancreatic cancer More than of people w ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Epigenetic Pharmacotherapy for Addiction
SBC: Epigenetix Inc Topic: R41PROJECT SUMMARY This proposal aims to develop a new small molecule drug to be advanced into human clinical trials for the treatment of cocaine addiction According to the National Institute on Drug Abuse illicit drug use cost the United States more than $ billion annually in expenses related to crime lost work productivity and health care Approximately million Americans aged or older ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of a kit for characterization of cellular energetics in single cells in cell and tissue cultures based on the measurement of the absolute magnitude of the mitochondrial membrane potential
SBC: Gerencser, Akos Topic: R41DESCRIPTION provided by applicant Altered cellular energetics contributes to human disease in general physiological aging and chronic diseases in particular including cancer neurodegeneration ischemic heart disease and type diabetes Pathological changes affecting the individual may arise only in specific cells of a tissue and potentially in a heterogeneous manner To advance basic resea ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Stabilization of Influenza Vaccine by Silica-Coating
SBC: STONESTABLE, INC. Topic: NIAIDThe goal of this Phase I STTR grant proposal is to stabilize live attenuated influenza vaccine LAIV using a temporary silica coating that is removed in vivo In so doing we will establish a broader technology to eliminate the cold chain required for transport of heat and cold labile vaccines Many vaccines are unstable under ambient environmental conditions Currently vaccines are either stabil ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Simple, low cost assay for detection of HIV-1 antiretroviral resistance in resource-limited settings
SBC: Discidium Biosciences, LLC Topic: NIAIDAntiretroviral therapy has become a reality in resource limited settings thanks to entities such as PEFAR and the Global Fund However contrary to the therapeutic choice flexibility in developed countries all patients go on reverse transcriptase inhibitor RTI based first line regimens with more expensive protease and integrase inhibitor based regimens being reserved as second line therapy for ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Sample-free onsite detection of cocaine using microneedles via laser-treated skin
SBC: AFASCI INC Topic: NIDADESCRIPTION provided by applicant The abuse of illicit drugs such as cocaine marijuana and heroin remains a critical public health concern throughout the country and is associated with staggering economic and social consequences Cocaine remains the most frequently recorded illicit drug in emergency hospital visits and the leading cause of drug related deaths in the United States Since as hi ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of a novel platform to enhance intracellular bioavailability of antisense morpholino oligomers
SBC: NAJIT TECHNOLOGIES INC Topic: NIAIDDESCRIPTION provided by applicant Peptide conjugated phosphorodiamidate morpholino oligomers PPMO are single stranded nucleic acid analogs able to modulate gene expression through steric blocking of complementary RNA PPMO are composed of two components an antisense morpholino oligomer cargo covalently conjugated to a cell penetrating delivery peptide PPMO are completely nuclease resistant ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health